调整闲置募集资金、自有资金现金管理额度及期限的核查意见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为江苏新瀚新材 料股份有限公司（以下简称"新瀚新材"或"公司"）首次公开发行股票并在创业板上市 的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票 上市规则》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运 作》等相关法律、法规和规范性文件的规定，对新瀚新材调整闲置募集资金、自有资 金现金管理额度及期限事项进行了核查，具体核查情况如下： 中泰证券股份有限公司 关于江苏新瀚新材料股份有限公司 一、募集资金的基本情况 经中国证券监督管理委员会2021年8月17日下发的《关于同意江苏新瀚新材料股份 有限公司首次公开发行股票注册的批复》（证监许可〔2021〕2688号），同意公司首次 公开发行人民币普通股（A股）股票2,000万股，每股发行价格为人民币31.00元，募 集资金总额人民币62,000.00万元，扣除发行费用（不含增值税）人民币6,524.15万元， 公司实际募集资金净额为人民币55,475.85万元。 公司募集资金已于2021年9月27日到账，天健 ...

经核查独立董事黄和发先生、仇连明先生、孙志刚先生的任职经历以及签署 的相关自查文件，上述人员未在公司担任除独立董事以外的任何职务，其配偶、 父母、子女、主要社会关系也未在公司任职，也未在公司主要股东公司担任任何 职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系。因此，公司独立董事符合 上市公司独立董事管理办法》 深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中对独立 董事独立性的相关要求。 江苏新瀚新材料股份有限公司董事会 2025 年 4 月 25 日 江苏新瀚新材料股份有限公司 董事会关于 2024 年度独立董事独立性自查情况的专项意见 根据《 中华人民共和国公司法》 上市公司独立董事管理办法》 深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规和 规范性文件及《 江苏新瀚新材料股份有限公司章程》的相关规定，江苏新瀚新材 料股份有限公司《 以下简称《 公司"）就 2024 年度在任独立董事黄和发先生、仇 连明先生、孙志刚先生提交的《 2024 年度独立董事独立性自查情况报告》进行评 估并出具如下专项意见： ...

江苏新瀚新材料股份有限公司 2024年度独立董事述职报告 （孙志刚） 本人孙志刚在2024年度担任江苏新瀚新材料股份有限公司（以下简称"公 司"）的独立董事，根据《公司法》、《证券法》、《上市公司独立董事管理办 法》、《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运 作》及《公司章程》的规定和要求，在2024年年度工作中忠实履行独立董事的职 责，本着客观、公正、独立的原则，勤勉尽责，积极发挥独立董事作用，维护公司 整体利益和全体股东尤其是中小股东的合法权益。现将2024年度履行职责情况述职 如下： 一、独立董事的基本情况 1978年出生，中国国籍，无境外永久居留权，硕士学历，产业经济学专业。 2010年6月至2010年10月任中信证券股份有限公司唐山营业部客户经理；2010年11 月至2011年7月任华创证券有限责任公司德阳营业部客户经理；2011 年9月至2013 年9月任国盛证券有限责任公司合肥翠微路营业部客户经理；2013年9 月至2014年2 月任美兰创新(北京)科技股份有限公司董事会办公室主任；2014年2月至2016年5月 任杭州天目山药业股份有限公司行政中心行政总监兼董事会办公 ...

江苏新瀚新材料股份有限公司 2024年度独立董事述职报告 （黄和发） 本人黄和发在2024年度担任江苏新瀚新材料股份有限公司（以下简称"公司"） 的独立董事，根据《公司法》、《证券法》、《上市公司独立董事管理办法》、 《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》及 《公司章程》的规定和要求，在2024年年度工作中忠实履行独立董事的职责，积极 出席相关会议，认真审议董事会各项议案，切实维护了公司的整体利益和全体股东 特别是中小股东的合法权益。现将2024年度履行职责情况述职如下： 一、独立董事的基本情况 自 2024 年1 月1 日至2024 年12 月31 日，公司共召开股东大会 3次。本人出席 3 次。 （二）出席董事会专门委员会及独立董事专门会议情况 1、参与董事会专门委员会工作的情况 本人作为公司董事会审计委员会主任委员，2024 年度召集、主持和参加公司董事 会专门委员会具体情况如下： 1965年出生，中国国籍，无境外永久居留权，硕士学历，金融与财务管理专业， 高级会计师。1986年7月至1994年9月任安徽安庆皖西水泥厂会计、副科长；1994年 10月至1999年2月任江苏 ...

江苏新瀚新材料股份有限公司 2024年度独立董事述职报告 （仇连明） 本人仇连明在2024年度担任江苏新瀚新材料股份有限公司（以下简称"公 司"）的独立董事，根据《公司法》、《证券法》、《上市公司独立董事管理办 法》、《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运 作》及《公司章程》的规定和要求，在2024年年度工作中认真履行职责，充分发挥 独立董事的作用，维护全体股东尤其是中小股东的利益，履行独立董事的职责，积 极出席相关会议，对各项议案进行认真审议，充分发挥独立董事及各专门委员会的 作用。现将2024年度履行职责情况述职如下： 一、独立董事的基本情况 1967年出生，中国国籍，无境外永久居留权，硕士学历，经济法专业。1988年 8月至1994年4月任江苏省龙潭监狱指导员；1994年4月至1995年10月任江苏省司法 厅编辑；1995年10月至2002年12月任江苏红五星律师事务所主任； 2003年1月至 2017年9月任江苏苏源律师事务所副主任；2017年10月至2020年12月任北京大成 （南京）律师事务所破产重组部主任、律师；江苏东交智控科技集团股份有限公司 独立董事；2021年1 ...

前十大流通股东累计持有： 1998.44万股，累计占流通股比： 28.83%，较上期变化： -4.45万股。 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 张萍 | 699.15 | 10.08 | 不变 | | 郝国梅 | 410.18 | 5.92 | 不变 | | 叶晓明 | 300.00 | 4.33 | -30.00 | | 汤浩 | 154.21 | 2.22 | 不变 | | 滕林栋 | 96.40 | 1.39 | 7.75 | | 张泽宇 | 83.25 | 1.20 | 不变 | | 周启宝 | 81.77 | 1.18 | 3.76 | | 李康 | 74.05 | 1.07 | 新进 | | 北京银杏盛鸿投资管理有限公司-盛鸿长青私募证券 投资基金 | 56.07 | 0.81 | 新进 | | 青骊投资管理(上海)有限公司-青骊汇川3号私募证券 | | | | | 投资基金 | 43.36 | 0.63 | 新进 | | 较上个报告期退出前十大股东有 | | | | | ...

Financial Performance - The company's operating revenue for 2024 was ¥419,462,944.08, a decrease of 3.66% compared to ¥435,406,568.95 in 2023[18]. - Net profit attributable to shareholders for 2024 was ¥55,966,075.49, down 40.04% from ¥93,341,126.16 in 2023[18]. - Basic earnings per share for 2024 decreased to ¥0.42, down 39.13% from ¥0.69 in 2023[18]. - The company reported a weighted average return on equity of 4.96% for 2024, down from 8.62% in 2023[18]. - The company's main business revenue for the chemical new materials segment was CNY 408.63 million, a decrease of 3.39% year-on-year, with a gross margin of 24.88%, down 8.38% from the previous year[83]. - The revenue from the core raw material for specialty engineering plastics decreased by 31.32% to 175.07 million yuan in 2024, compared to 254.90 million yuan in 2023[81]. - The revenue from cosmetic raw materials increased by 77.32% to 93.58 million yuan in 2024, compared to 52.78 million yuan in 2023[81]. - The company reported a total fundraising amount of 620 million yuan, with a net amount of 554.79 million yuan raised[112]. Cash Flow and Investments - The cash flow from operating activities increased significantly to ¥139,428,467.82, a 525.70% increase from ¥22,283,603.87 in 2023[18]. - The net cash flow from operating activities increased by 525.70% year-on-year, reaching ¥139,428,467.82, primarily due to increased sales efforts and reduced inventory levels[96]. - The net cash flow from investment activities decreased by 248.53% year-on-year, resulting in a net outflow of ¥274,445,729.09, mainly due to increased idle funds in financial management[96]. - The total cash and cash equivalents decreased by 204.25% year-on-year, amounting to a net decrease of ¥152,529,899.06, primarily due to increased idle funds and trading financial assets[96]. - The company's total investment amount for the reporting period was ¥1,509,599,407.13, representing a 31.33% increase compared to ¥1,149,485,223.32 in the previous year[105]. Shareholder and Governance Matters - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares, totaling 13,452,400 RMB, which represents 100% of the profit distribution[191][192]. - The company will also increase its capital by issuing 3 additional shares for every 10 shares held, based on a total share capital of 134,524,000 shares[192]. - The company held three shareholder meetings during the reporting period, ensuring compliance with legal procedures and enhancing shareholder participation through both in-person and online voting methods[145]. - The board of directors consists of 9 members, including 3 independent directors, and held seven meetings, adhering to relevant laws and regulations[146]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, with no instances of asset occupation or financial guarantees provided to related parties[148][151][152][153][154]. Market and Product Development - The company’s main business involves the research, production, and sales of aromatic ketone products, including specialty engineering plastics and photoinitiators[28]. - Major clients include international chemical groups such as SYENSQO, VICTREX, and EVONIK, indicating a strong market presence[29]. - The company is focusing on expanding its applications in aerospace, IT manufacturing, and biomedical sectors, leveraging the unique properties of its products[33]. - The company aims to produce 8,000 tons of aromatic ketones annually, optimizing production structure to enhance profitability and exploring new profit growth points through collaboration with downstream clients and research institutions[60]. - The company is expanding its product line in specialty engineering plastics and cosmetic raw materials, aiming for breakthroughs in product offerings[60]. Research and Development - The company has ongoing R&D projects aimed at improving product yield and purity, which are expected to create new profit growth points[93]. - The company has established a mechanism for talent development to support its expanding business needs, ensuring a skilled workforce for future growth[129]. - The company is committed to ongoing research and development in high-performance materials[163]. - The company has implemented innovative technologies that reduce emissions and enhance production safety, contributing to improved product quality and customer trust[69]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, highlighting potential operational risks[4]. - The company faces risks from intensified market competition and raw material cost fluctuations, which could lead to a decline in gross margin[136]. - To mitigate gross margin risks, the company has established long-term relationships with key suppliers to secure better pricing through fixed and large-scale procurement[136]. Employee and Management Practices - The company has a comprehensive employee welfare system, including health insurance and retirement benefits, to ensure employee satisfaction and retention[189]. - The company has established a performance-based compensation system to align employee salaries with their job performance and contributions[189]. - The company has implemented a performance-based bonus system for senior management, linking bonuses to annual operational performance[196]. - The company has a structured governance system with no differential voting rights arrangements in place[159]. Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue increase of 20% to $600 million[3]. - The company plans to actively explore new international markets and develop new products to reduce reliance on export revenues[139]. - The company plans to enhance its product offerings in the cosmetic raw materials sector by seeking breakthroughs in product formulations[126].

Financial Performance - The company's revenue for Q1 2025 reached ¥115,730,444.24, representing a 12.43% increase compared to ¥102,937,425.64 in the same period last year[4] - Net profit attributable to shareholders was ¥16,188,059.34, a significant increase of 47.85% from ¥10,948,940.01 year-on-year[4] - Basic earnings per share rose to ¥0.12, reflecting a 50.00% increase from ¥0.08 in the same quarter last year[4] - Net profit for the current period was ¥16,188,059.34, representing a 47.5% increase from ¥10,948,940.01 in the previous period[17] - Operating profit rose to ¥18,336,121.49, a 50.0% increase compared to ¥12,216,487.97 in the previous period[17] Cash Flow - The net cash flow from operating activities improved to ¥2,675,719.68, a remarkable increase of 242.86% compared to a negative cash flow of -¥1,873,019.37 in the previous year[4] - Cash flow from operating activities generated a net amount of ¥2,675,719.68, recovering from a negative cash flow of ¥1,873,019.37 in the previous period[19] - The company reported a net cash flow from investment activities of ¥6,779,993.96, compared to a negative cash flow of ¥29,007,990.86 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,265,510,987.30, up 0.93% from ¥1,253,854,801.37 at the end of the previous year[4] - The total liabilities decreased to ¥100,427,113.32 from ¥106,341,078.65, reflecting a reduction of about 5.5%[14] - The company's retained earnings increased to ¥397,775,880.18 from ¥381,587,820.84, showing a growth of approximately 4.2%[15] - The total equity attributable to the owners of the parent company rose to ¥1,165,083,873.98 from ¥1,147,513,722.72, which is an increase of about 1.5%[15] Investments and Income - The company reported a significant increase in investment income to ¥4,855,259.71, up 539.55% from ¥759,168.76 in the previous year[7] - Cash inflow from investment activities totaled ¥549,862,339.36, significantly higher than ¥112,061,267.48 in the previous period[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,099, with the largest shareholder holding 25.55% of the shares[9] - The total number of common shareholders at the end of the reporting period is 16,099[10] - The number of shareholders holding more than 5% of shares includes 郝国梅 with 3.05% and 4,101,809 shares[10] - The company has no preferred shareholders or changes in restricted shares during the reporting period[11] Operating Costs - Total operating costs increased to ¥101,930,395.10, up 14.1% from ¥89,407,156.76 in the previous period[16] - Management expenses rose by 56.51% to ¥10,017,590.73, mainly due to increased safety and environmental costs[7] Inventory and Receivables - Accounts receivable increased by 47.78% to ¥90,772,100.80, primarily due to outstanding customer payments within the credit period[7] - Accounts receivable rose significantly to ¥90,772,100.80 from ¥61,421,802.68, marking an increase of about 47.8%[13] - The company reported a significant increase in inventory, which decreased to ¥52,311,593.02 from ¥55,114,626.83, a decline of about 5.1%[13] Audit Information - The company did not undergo an audit for the first quarter report[21]

截至4月25日收盘，PEEK材料概念下跌1.53%，位居概念板块跌幅榜前列，板块内，新瀚新材、中研股 份、道恩股份等跌幅居前，股价上涨的有7只，涨幅居前的有中欣氟材、金发科技、崇德科技等，分别 上涨2.44%、0.84%、0.83%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 生物质能发电 | 1.92 | 中韩自贸区 | -1.94 | | F5G概念 | 1.62 | 重组蛋白 | -1.56 | | 钛白粉概念 | 1.62 | PEEK材料 | -1.53 | | 抽水蓄能 | 1.44 | 草甘膦 | -1.47 | | 共封装光学(CPO) | 1.41 | 肝炎概念 | -1.43 | | 碳交易 | 1.37 | CRO概念 | -1.42 | | 绿色电力 | 1.35 | 青蒿素 | -1.38 | | 短剧游戏 | 1.35 | 赛马概念 | -1.34 | | 光纤概念 | 1.35 | 乳业 | -1.32 | | 举牌 | 1.32 | 维生素 | -1.30 | 资金面上看 ...